核素心肌灌注断层显像诊断冠心病的临床应用  

Diagnostic value of ^(99m)Tc-MIBI myocardial perfusion imaging in patients with coronary artery disease

作　　者：欧阳小青[1] 欧阳亮[1] 王鲁华[1] 方琳丽[1] 林琛[1] 关楚文[1] 

机构地区：[1]汕头大学医学院第一附属医院药剂科,广东汕头515041

出　　处：《中国校医》2008年第1期94-95,共2页Chinese Journal of School Doctor

摘　　要：目的评估核素心肌灌注断层显像在冠心病(CAD)临床诊断中的价值。方法对30例冠心病和可疑冠心病患者进行99m锝-甲氧基异丁基异晴(99mTc-MIBI)心肌灌注断层显像,同时采用半定量方法分析患者左心室心肌血流灌注情况,其中15例患者行冠状动脉造影术(CAG)。结果心肌灌注断层显像冠心病和可疑冠心病患者检查的阳性率为46.7%。结论99mTc-MIBI心肌灌注断层显像是安全、无创伤、方便及费用低的检查方法,临床联合应用对冠心病的诊断、治疗和预后判断有重要的价值。Objective To evaluate the value of ^99mTc-MIBI myocardial perfusion imaging in patients with coronary artery disease （CAD）, Methods Thirty patients with CAD or suspect CAD received ^99mTc- MIBI myocardial perfusion imaging, and 15 patients received coronary artery angiography. Half-quantity analysis was performed. Results The positive rate of the ^99mTc-MIBI myocardial perfusion imaging was 46.7% in patients with CAD or suspect CAD. Conclusions The ^99mTc- MIBI myocardial perfusion imaging is effective, safe, and painless in the diagnoses of patients with coronary artery disease.

关 键 词：X线断层显像术 发射计算机 单光子 冠心病 冠状动脉造影术 ^99m锝-甲氧基异丁基异晴 

分 类 号：R543.31[医药卫生—心血管疾病]